All News

Derazantinib is an investigational oral inhibitor of FGFR1, FGFR2, and FGFR3 in patients with locally advanced or metastatic intrahepatic cholangiocarcinoma.

Pharmacists can coordinate education programs for patients to normalize quality of life and minimize infusion-related pain.

On this month's list of Rx products is an FDA-updated label for a cardiovascular disease drug, 2 FDA-approved NDAs for schizophrenia and alopecia areata, and an FDA approved treatment for pustular psoriasis.

GSK3036656 demonstrates early bactericidal activity with a low, once-daily oral dose after 14 days of treatment.

The implementation of negative control outcomes and a complementary cohort demonstrate an estimated beneficial effect that associated with an individual’s overall health.

Study suggests that high levels of nicotinamide riboside could increase the risk of developing triple-negative breast cancer and may cause the cancer to metastasize to the brain.

The trial data demonstrated that pembrolizumab in combination with chemotherapy also had statistically significant and clinically meaningful improvements in PFS and ORR as well.

Patients with lung cancer in an early-intervention lung screening program were found to have a survival rate nearly 20-times longer than patients with a late-stage diagnosis.

Instagram offers a myriad of ways to share content and connect with others.

Walgreens plans to focus on improving pharmacy staffing and retaining and rewarding current staff.

Study results show that patients with moderate or severe immune suppression should be considered a priority for additional vaccine doses and risk-reduction strategies.

This issue's OTC Cases answer common questions about a cough.

Pharmacists play a significant role in the comprehensive management of this condition through education, intervention, and monitoring.

Leveraging pharmacogenomic testing, simultaneous multidrug analysis can help prevent drug interactions affecting pain management.

Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.

Legislation expands protection of original 1965 act to individuals younger than 60 years.

Pharmacists should engage patients, explore system fixes to prevent missed drug-drug interactions

CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.

The adeno-associated virus vector-based gene therapy is the first gene therapy to be approved by the FDA for hemophilia B.

Decision on payment reductions looks fleeting as ruling also provides HHS with instructions on cost-cutting goals.

For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.

List of our November 2022 picks for generic products.

As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.

Study finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.

Patients with cystic fibrosis may benefit from a 1000 mg vitamin C supplement, which can increase the bioavailability of other antioxidants.

IPX203 is a novel, oral formulation of carbidopa/levodopa extended-release capsules.